Palisade Bio, Inc.
PALI· Nasdaq
PALIPalisade Bio, Inc.
Released Mar 23, 2017, after the close
10-K filed Mar 23, 2017, 82 days after period end · 0001171843-17-001704
derived · Computed from the longer spans the company filed.
| Metric | Q4 2016dderived from reported figures | Q4 2015 | Q4 2014 | Q4 2013 |
|---|---|---|---|---|
| Revenue | $8.75K | $2.50K | $4.67K | $2.50K |
| Net Income | -$5.40M | -$4.77M | -$5.50M | -$3.30M |
Palisade Bio, Inc. · CIK 1357459 · Engraved from SEC EDGAR
| EPS Diluted | — | -$0.05 | -$0.06 | -$0.04 |
|---|
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
